Note 8 - Accounts Payable and Accrued Liabilities |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Notes to Financial Statements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounts Payable and Accrued Liabilities Disclosure [Text Block] |
8. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
Accounts payable includes $228 and $53 due to related party Syzygy Licensing, LLC (“Syzygy”) as of December 31, 2021 and 2020, respectively. Accounts payable at December 31, 2020 also included $10 due to related party V3 Capital Partners, LLC.
Accrued liabilities consist of the following:
Accrued compensation includes $305 and $563 in employee bonuses and commissions payable at December 31, 2021 and 2020, respectively. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||